Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 84.47
(0.86%)
CNY 84.47
(0.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 492.43 Million CNY | 37.98% |
| 2022 | 356.87 Million CNY | 12.99% |
| 2021 | 315.85 Million CNY | 47.17% |
| 2020 | 214.61 Million CNY | 51.4% |
| 2019 | 141.75 Million CNY | 56.38% |
| 2018 | 90.64 Million CNY | 43.01% |
| 2017 | 63.38 Million CNY | 54.17% |
| 2016 | 41.11 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 219.22 Million CNY | 18.95% |
| 2024 Q1 | 184.29 Million CNY | 77.2% |
| 2024 Q3 | 149.81 Million CNY | -31.66% |
| 2023 Q4 | 104 Million CNY | -4.49% |
| 2023 Q3 | 108.9 Million CNY | -29.6% |
| 2023 Q2 | 154.68 Million CNY | 23.91% |
| 2023 FY | 492.43 Million CNY | 37.98% |
| 2023 Q1 | 124.84 Million CNY | 122.95% |
| 2022 Q2 | 91.55 Million CNY | -25.86% |
| 2022 Q1 | 123.48 Million CNY | 87.47% |
| 2022 Q3 | 85.84 Million CNY | -6.23% |
| 2022 FY | 356.87 Million CNY | 12.99% |
| 2022 Q4 | 55.99 Million CNY | -34.77% |
| 2021 Q3 | 65.27 Million CNY | -21.37% |
| 2021 Q4 | 65.87 Million CNY | 0.91% |
| 2021 FY | 315.85 Million CNY | 47.17% |
| 2021 Q2 | 83.01 Million CNY | -18.36% |
| 2021 Q1 | 101.68 Million CNY | 94.76% |
| 2020 Q2 | 61.05 Million CNY | 2.66% |
| 2020 Q1 | 59.47 Million CNY | 103.54% |
| 2020 FY | 214.61 Million CNY | 51.4% |
| 2020 Q4 | 52.2 Million CNY | 24.71% |
| 2020 Q3 | 41.86 Million CNY | -31.44% |
| 2019 Q3 | 27.52 Million CNY | -31.79% |
| 2019 Q2 | 40.34 Million CNY | -9.66% |
| 2019 Q1 | 44.66 Million CNY | 206.71% |
| 2019 FY | 141.75 Million CNY | 56.38% |
| 2019 Q4 | 29.22 Million CNY | 6.19% |
| 2018 Q1 | 32.76 Million CNY | 0.0% |
| 2018 FY | 90.64 Million CNY | 43.01% |
| 2018 Q4 | 14.56 Million CNY | -6.62% |
| 2018 Q3 | 15.59 Million CNY | -43.75% |
| 2018 Q2 | 27.72 Million CNY | -15.39% |
| 2017 FY | 63.38 Million CNY | 54.17% |
| 2016 FY | 41.11 Million CNY | 0.0% |